Home
Flashcards
Preview
ADT Exam 1
Home
Get App
Take Quiz
Create
Major drug absorption takes place in
small intestine
high surface area
large blood supply
Drug absorption pathways
passive diffusion
facilitated transport
active transport
phagocytosis/pinocytosis
Most drugs are absorbed via
passive diffusion
Absorption of the drug from the gut depends on
gastric emptying
intestinal motility
mucosal surface area
degradation of the drug in the stomach (pH)
metabolizing enzymes in the gut
slows gastric emptying and motility
food
increased calories
do not want drug in stomach more than ___ min to avoid degredation from low pH
15 min
60% of drug delivery systems
Oral CR
Oral sustained and controlled release products
avoids frequent dosing
involves use of biodegradeable polymers
can result in toxicity if dosing regimen not followed
tylenol sustained release could result in
liver toxicity
six types of oral controlled drug delivery
physical
chemical
osmotic
diffusion
dissolution
targeted
Goals of oral controlled release systems
better control over systemic concentrations
sustained level of drug after a single dose
decrease pill burden
disadvantages of OCRS
dose dumping can occur
removal of drug from systemic circulation is impossible
erratic or variable drug absorption
Physically controled drug delivery
altering absorption by altering viscosity of the formulation
Most soluble form to least soluble form
solution
suspension
capsule
tablet
coated tablet
particle size with fastest absorption
small
Chemically modified drug delivery
prodrugs
salt forms
esters
Osmotically controlled drug delivery (push-pull)
drug embedded in polymer with a laser driven pore
water comes in from the GIT and dissolves sugar, pushing drug solution through the delivery orafice
osmotically controlled drug delivery (L-oros)
drug enclosed in soft gelatin capsule
inner membrane
osmotic push layer
rate controlling membrane
delivery orifice
Rate controlling membrane of L-OROS system
membrane controlls how much water comes in
ensures constant pressure for same release
OROS Tri-layer
more for solids
2 drug compartments that have different release rates
1 push compartment
rate controlling membrane
overcoat
delivery orifice
First once a day treatment for overactive bladder
Ditropan XL
dM/dt=K(A/h)(x)C
s
the rate at which drug is pumped out of the osmotic system through orifice
dM/dt = amount of drug in mg delivered per unit of time in hours
Cs concentration of the saturated solution (constant)
K membrane permeability (mg/hr)
x is the osmotic pressure
The rate of drug release ____ until the excess undissolved drug is depleted
zero-order (constant)
Non-zero order release sets in when
the saturated concentration (Cs) becomes unsaturated
Advantages of OROS
enhanced bioavailability
patterned release
reduced variability
Diffusion controlled system
drug diffuses through a matrix at a constant rate
polymers for diffusion (matrix) control
PLGA
PEG
Polyacrylamide
PVA
xanthan and guar gums
typical commercial product that utilizes matrix diffusion
nifedipine er
Encapsulated dissolution controlled system
once coating is dissolved drug core is available for immediate release and absorption
control of encapsulated dissolution time
thickness of polymeric membrane
compressing multiple particles of varying thickness of drug
Examples of materials used for micro encapsulation
cellulose
shellac
gelatin
carnuba wax
dC/dt=k(A/V)(Cs-C)
estimates drug release from dissolution controlled system
dC = dissolution rate
V = volume of solution
k = dissolution rate constant
A = surface area of exposed solid
Enteric coating of tablets are designed to release drug
in the small intestine or large intestine
coating that allows for release in large intestine
chitosan polymers
Author
Rx2013
ID
107889
Card Set
ADT Exam 1
Description
Oral Controlled Release
Updated
2011-10-11T00:10:40Z
Show Answers
Home
Flashcards
Preview